반응식
[CH3:1][N:2]1[CH2:7][CH2:6][C:5](=[N:8][OH:9])[CH2:4][CH2:3]1.C([O-])(=O)C.C([O-])(=O)C.C([O-])(=O)C.C([O-])(=O)C.[Pb+4].[P:27]([O-:39])([O:34][CH2:35][CH2:36][CH2:37][CH3:38])([O:29][CH2:30][CH2:31][CH2:32][CH3:33])=[O:28]>>[P:27]([O:39][C:5]1([N:8]=[O:9])[CH2:6][CH2:7][N:2]([CH3:1])[CH2:3][CH2:4]1)([O:29][CH2:30][CH2:31][CH2:32][CH3:33])([O:34][CH2:35][CH2:36][CH2:37][CH3:38])=[O:28]참가 물질
4
실험 절차
Dibutyl 1-methyl-4-nitrosopiperidin-4-yl phosphate was prepared from 1-methyl-piperidin-4-one oxime, lead tetraacetate and dibutyl phosphate using conditions of General Method 3. 1H NMR (360 MHz, chloroform-d) δ 4.03-4.17 (4H, m), 2.77-2.88 (2H, m), 2.27-2.40 (6H, m), 2.12-2.24 (4H, m), 1.59-1.83 (6H, m), 1.38 (4H, q, 7.2 Hz).
출처 및 근거
- ORD 기록
- ord-d66f9610286443bd9b81dc06709a5987
- 출처 데이터셋
- uspto-grants-2014_07
- 특허 번호
- US08791134B2
연결된 노트
불러오는 중…